TNF and type 1 diabetes mellitus: Interestingly, TNF-α activating treatments have been shown to be anti-inflammatory through selectively destroying autoreactive T lymphocytes in T1DM patients and mice models [19, 20] and furthermore, causing the expansion of anti-inflammatory T regulatory cells [21].